基本信息
views: 1
Career Trajectory
Bio
No content for now
Research Interests
Papers共 121 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER MEDICINEno. 8 (2024)
Noboru Yamamoto,Takafumi Koyama,Jun Sato,Tatsuya Yoshida,Kazuki Sudo,Satoru Iwasa,Shunsuke Kondo,Kan Yonemori,Atsuko Kawasaki, Kyoko Satake, Shoyo Shibata,Toshio Shimizu
Cancer Chemotherapy and Pharmacologypp.1-7, (2024)
Noboru Yamamoto,Yasutoshi Kuboki,Kenichi Harano,Takafumi Koyama,Shunsuke Kondo, Akiko Hagiwara, Noriko Suzuki, Ei Fujikawa,Kiichiro Toyoizumi, Mayumi Mukai,Toshihiko Doi
Investigational new drugs (2024)
Noboru Yamamoto,Yasutoshi Kuboki,Kenichi Harano,Takafumi Koyama,Shunsuke Kondo, Akiko Hagiwara, Noriko Suzuki, Ei Fujikawa,Kiichiro Toyoizumi, Mayumi Mukai,Toshihiko Doi
Investigational New Drugs (2024)
Erisa Fujii,Mayumi Kobayashi Kato, Maiko Yamaguchi, Daiki Higuchi,Takafumi Koyama, Masaaki Komatsu, Ryuji Hamamoto,Mitsuya Ishikawa,Tomoyasu Kato,Takashi Kohno,Kouya Shiraishi,Hiroshi Yoshida
Scientific reportsno. 1 (2024): 13058-13058
Noboru Yamamoto,Takafumi Koyama,Jun Sato,Tatsuya Yoshida,Kazuki Sudo,Satoru Iwasa,Shunsuke Kondo,Kan Yonemori,Atsuko Kawasaki, Kyoko Satake, Shoyo Shibata,Toshio Shimizu
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2024)
Noboru Yamamoto,Yasutoshi Kuboki,Kenichi Harano,Takafumi Koyama,Shunsuke Kondo, Akiko Hagiwara, Noriko Suzuki, Ei Fujikawa,Kiichiro Toyoizumi, Mayumi Mukai,Toshihiko Doi
Investigational New Drugspp.1-10, (2024)
Yuki Katsuya,Kan Yonemori,Toshio Shimizu,Takafumi Koyama, Sigehisa Kitano,Kazuki Sudo,Shunsuke Kondo,Jun Sato, Hiroaki Hozumi,Noboru Yamamoto
Cancer Researchno. 7_Supplement (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn